NCT00299988View on ClinicalTrials.gov

Phase II Study of Intravenous Immunoglobulin (IVIg) for Alzheimer's Disease

PHASE2TerminatedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

January 31, 2009

Study Completion Date

April 30, 2010

Conditions

Alzheimer's Disease

Interventions

DRUG

Intravenous Immunoglobulin

OTHER

Placebo

Trial Locations (1)

10021

Weill Medical College of Cornell University, New York

Sponsors

Collaborators (1)

Baxter BioScience

All Listed Sponsors

collaborator

Baxter BioScience

INDUSTRY

collaborator

National Institutes of Health (NIH)

NIH

lead

Weill Medical College of Cornell University

OTHER